Evidence map›Paper›PMID 24101724›Full record

ArticleJournal of cell science2013

Dynamic mitochondrial-nuclear redistribution of the immunophilin FKBP51 is regulated by the PKA signaling pathway to control gene expression during adipocyte differentiation.

Judith Toneatto, Sergio Guber, Nancy L Charó, Sebastián Susperreguy, Jessica Schwartz, Mario D Galigniana, Graciela Piwien-Pilipuk

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cell science, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Neurobiology of stress · 2025
    Review
  3. Article
  4. Knocking out Fkbp51 decreases CClCell & bioscience · 2024
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. AmotL2, IQGAP1, and FKBP51 Scaffold Proteins in Glioblastoma Stem Cell Niches.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2022
    Review
  13. FKBP51 and the molecular chaperoning of metabolism.Trends in endocrinology and metabolism: TEM · 2021
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. IQGAP1, AmotL2, and FKBP51 Scaffoldins in the Glioblastoma Microenvironment.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2019
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Judith ToneattoLaboratory of Nuclear Architecture, Instituto de Biología y Medicina Experimental (IByME) - CONICET, Buenos Aires C1428ADN, Argentina.
Sergio Guber
Nancy L Charó
Sebastián Susperreguy
Jessica Schwartz
Mario D Galigniana
Graciela Piwien-Pilipuk
Experimental Medicine and Biology Institute · ARConsejo Nacional de Investigaciones Científicas y Técnicas · ARFundación Ciencias Exactas y Naturales · ARUniversity of Michigan–Ann Arbor · US

Funding

C/EBPb and heterochromatin: their role in adipogenesisR03TW008143 · FIC · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SCHWARTZ, JESSICA · 2009 to 2011
$103k
FIC NIH HHS R03 TW008143FIC NIH HHS R03TW008143-01A1
6 · The paper itself

Abstract

Glucocorticoids play an important role in adipogenesis through the glucocorticoid receptor (GR) that forms a heterocomplex with Hsp90•Hsp70 and one high molecular weight immunophilin, either FKBP51 or FKBP52. When 3T3-L1 preadipocytes are induced to differentiate, FKBP51 expression progressively increases, whereas FKBP52 decreases, and Hsp90, Hsp70, p23 and Cyp40 remain unchanged. Interestingly, FKBP51 rapidly translocates from mitochondria to the nucleus where it is retained upon its interaction with chromatin and the nuclear matrix. FKBP51 nuclear localization is transient, and after 48 hours it cycles back to mitochondria. Importantly, this dynamic FKBP51 mitochondrial-nuclear shuttling depends on PKA signaling, because its inhibition by PKI or knockdown of PKA-cα by siRNA, prevented FKBP51 nuclear translocation induced by IBMX. In addition, the electrophoretic pattern of migration of FKBP51 is altered by treatment of cells with PKI or knockdown of PKA-cα, suggesting that FKBP51 is a PKA substrate. In preadipocytes, FKBP51 colocalizes with PKA-cα in mitochondria. When adipogenesis is triggered, PKA-cα also moves to the nucleus colocalizing with FKBP51 mainly in the nuclear lamina. Moreover, FKBP51 and GR interaction increases when preadipocytes are induced to differentiate. GR transcriptional capacity is reduced when cells are incubated in the presence of IBMX, forskolin or dibutyryl-cAMP, compounds that induced FKBP51 nuclear translocation, but not by a specific activator of EPAC. FKBP51 knockdown facilitates adipogenesis, whereas ectopic expression of FKBP51 blocks adipogenesis. These findings indicate that the dynamic mitochondrial-nuclear shuttling of FKBP51 regulated by PKA may be key in fine-tuning the transcriptional control of GR target genes required for the acquisition of adipocyte phenotype.

Indexed as

Gene Expression Regulation1-Methyl-3-isobutylxanthine3T3-L1 CellsAdipogenesisAnimalsCell DifferentiationCell NucleusChromatinColforsinCyclic AMP-Dependent Protein KinasesHSP70 Heat-Shock ProteinsHSP90 Heat-Shock ProteinsMiceMitochondriaPeptidesProtein Binding1-Methyl-3-isobutylxanthineChromatinColforsinCyclic AMP-Dependent Protein KinasesHSP70 Heat-Shock ProteinsHSP90 Heat-Shock ProteinsPeptidesProtein Kinase C-alphaProtein Kinase InhibitorsReceptors, GlucocorticoidRNA, Small InterferingTacrolimus Binding Protein 5Tacrolimus Binding ProteinsAdipogenesisFKBP51Glucocorticoid receptorPKA

Identifiers

PMID24101724
PMCPMC3843136
OpenAlexW2128786847

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.